Document Detail


Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation.
MedLine Citation:
PMID:  19602049     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Severe haemorrhage is a common cause of death despite the recent advances in critical care. Conventional resuscitation fluids are designed to re-establish tissue perfusion, but they fail to prevent inflammatory responses during resuscitation. Our previous studies indicated that the vagus nerve can modulate systemic inflammation via the alpha7 nicotinic acetylcholine receptor (alpha7nAchR). Here, we report that the alpha7nAChR-agonist, GTS, restrains systemic inflammation and improves survival during resuscitation. Resuscitation with GTS rescued all the animals from lethal haemorrhage in a concentration-dependent manner. Unlike conventional resuscitation fluids, GTS inhibited the production of characteristic inflammatory and cardiodepressant factors including tumour necrosis factor (TNF) and high mobility group B protein-1 (HMGB1). Resuscitation with GTS was particularly effective in restraining systemic TNF responses and inhibiting its production in the spleen. At the molecular level, GTS inhibited p65RelA but not RelB NF-kappaB during resuscitation. Unlike non-specific nicotinic agonists, GTS inhibited serum protein TNF levels in both normal and splenectomized, haemorrhagic animals. Resuscitation with GTS inhibited poly(ADP-ribose) polymerase and systemic HMGB1 levels. Our studies suggest that GTS provides significant advantages as compared with non-specific nicotinic agonists, and it could be a promising anti-inflammatory supplement to improve survival during resuscitation.
Authors:
Bolin Cai; Fei Chen; Yan Ji; Levente Kiss; Wouter J de Jonge; Concepcion Conejero-Goldberg; Csaba Szabo; Edwin A Deitch; Luis Ulloa
Related Documents :
16818669 - Role of hmgb1 in apoptosis-mediated sepsis lethality.
12841559 - Dissemination of bacteria in multiple organs associated with apoptosis and macrophage a...
16552219 - Nutrients with immune-modulating effects: what role should they play in the intensive c...
20953969 - Stimulation of tlr7 prior to polymicrobial sepsis improves the immune control of the in...
8943639 - Endotoxin, cellular immune dysfunction and acute pancreatitis.
19906009 - High mobility group box 1 protein as a potential drug target for infection- and injury-...
11899069 - Measles virus induced immunosuppression: targets and effector mechanisms.
11349089 - Pyrogenicity and cytokine-inducing properties of streptococcus pyogenes superantigens: ...
19679109 - Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2008-10-17
Journal Detail:
Title:  Journal of cellular and molecular medicine     Volume:  13     ISSN:  1582-4934     ISO Abbreviation:  J. Cell. Mol. Med.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2010-03-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101083777     Medline TA:  J Cell Mol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  3774-85     Citation Subset:  IM    
Affiliation:
Laboratory of Anti-inflammatory Signaling and Surgical Immunology, UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
GM084125/GM/NIGMS NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis.
Next Document:  Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.